Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2014 | 12-2013 | 10-2013 | 09-2013 | 07-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4 | -120 | N/A | -90 | 1 |
| Depreciation Amortization | 2 | N/A | N/A | N/A | 9 |
| Accounts receivable | -10 | N/A | N/A | N/A | -22 |
| Other Working Capital | -10 | 120 | N/A | 90 | -17 |
| Other Operating Activity | 10 | 0 | 0 | 0 | 24 |
| Operating Cash Flow | $-4 | $N/A | $N/A | $N/A | $-6 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -38 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-38 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 27 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 32 |
| Debt Repayment | -6 | N/A | N/A | N/A | -5 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 25 |
| Other Financing Activity | -23 | 0 | 0 | 0 | 3 |
| Financing Cash Flow | $-2 | $N/A | $N/A | $N/A | $55 |
| Beginning Cash Position | 52 | N/A | N/A | N/A | 26 |
| End Cash Position | 47 | N/A | N/A | N/A | 37 |
| Net Cash Flow | $-6 | $N/A | $N/A | $N/A | $11 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4 | N/A | N/A | N/A | -6 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -49 |
| Free Cash Flow | -4 | 0 | 0 | 0 | -55 |